First Patient in Minnesota Receives TG Therapeutics’ New Multiple Sclerosis Drug at Infusion Associates Outpatient Infusion Center
PLYMOUTH, Minn., March 8, 2023 /PRNewswire/ — Infusion Associates (IA), one of the Midwest’s leading providers of medically prescribed outpatient infusion and injection therapies, completed their first Briumvi™ (ublituximab-xiiy) infusion treatment for a patient at their Plymouth, Minnesota location. Infusion Associates is the first healthcare facility in Minnesota to administer the new FDA approved drug treating […]